Prime editing fixed a rare immune disorder in stem cells with 70% efficiency and no off-target hits

Key Findings

💉 A lipid nanoparticle built for big cargo edits brain, liver, and lung

• Standard lipid nanoparticles lose potency as RNA cargo gets larger. Researchers screened 384 lipid variants using a 5.7-kilobase RNA and found one — LC-1 — that holds its structure as cargo size grows.
• After injection, LC-1 achieved up to 79% gene knockout in liver, 48% in brain, and 27% in lung — up to fourfold higher than leading benchmarks across all three routes of administration.

⚠️ CRISPR edits in stem cell models hide more than PCR can find

• Standard PCR-based genotyping missed inversions, plasmid DNA integrations, and complex structural rearrangements in CRISPR-edited human stem cell lines. A hybridization capture sequencing approach caught what PCR missed — and revised the interpretation of several clones.
• The finding matters because isogenic stem cell pairs are a gold standard for disease modeling. Undetected edits can silently distort any experiment built on top of them.

🔬 Blocking one DNA repair protein boosts prime editing insertions twofold

• A screen of 569 compounds found that PARP inhibitors — drugs already in clinical use for cancer — selectively doubled prime editing efficiency for insertions at one genomic site, without increasing errors or improving substitution edits.
• The effect held in primary human T cells and across multiple prime editing architectures, but was locus-dependent, meaning it won't be a universal switch.

👴 A mutation-agnostic base editor rescues a premature aging syndrome in organoids

• Hutchinson-Gilford progeria syndrome causes rapid aging and is driven by a toxic protein that requires a specific chemical tag (farnesylation) to do damage. Researchers designed a base editor — FATE — that disrupts the tagging site without touching other proteins that need the same modification.
• In lab-grown neuromuscular tissue derived from patient stem cells, FATE eliminated the toxic protein accumulation, restored DNA repair activity, and normalized nuclear architecture. Delivery used lipid nanoparticles carrying base editor mRNA.

💊 Separating the side effects of nucleic acid therapies from their benefits

• mRNA vaccines, AAV vectors, and lipid nanoparticle gene editors all trigger a shared inflammatory spike about six hours after dosing — driven by the nucleic acid cargo itself, not the lipid shell. Suppressing that early response with endosomal sensing inhibitors reduced reactogenicity without blunting immune responses or editing efficiency.
• The result suggests the inflammatory cost of these therapies is not mechanically required for them to work — a distinction that could widen dosing flexibility.

🩸 Base editing corrects a common blood disorder by targeting the symptom, not the mutation

• A form of beta-thalassemia prevalent in Han Chinese populations involves a mutation that creates a rogue splice site — causing the cell to cut its RNA in the wrong place. Direct editing of the mutation is difficult because no good guide RNA can reach it.
• Researchers instead targeted the aberrant splice site itself. In a mouse model, base editing restored correct RNA splicing in 86% of successfully edited animals, with marked improvements in blood cell counts and tissue health.